先聲藥業(02096.HK)先必新舌下片新適應臨床試驗獲批

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

先聲藥業(02096.HK)先必新舌下片新適應臨床試驗獲批

阿思達克 12-01 00:37

先聲藥業(02096.HK)公布，集團與寧丹新藥合作的先必新舌下片新適應症獲中國國家藥品監督管理局簽發的藥物臨床試驗批准通知書，擬開展用於急性缺血性卒中患者中預防性治療卒中後認知功能障礙的臨床試驗。

先聲藥業(02096.HK)

Relevant Stocks

先聲藥業(02096.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

先聲藥業(02096.HK)先必新舌下片新適應臨床試驗獲批

Services

About Us

Agreement Statement